videos

Patent Expirations Play Video

Patent Expirations

9.2010 | Interview | North America

Robert Brown of Eli Lilly & Co. explains that the biggest challenge faced by pharmaceutical marketing in 2011 is the expiration of patents. The marketing paradigm is shifting from big blockbusters to smaller-scale products and more targeted audiences. Digital lends itself well to that paradigm of marketing.
Measurement and Display Ads Play Video

Measurement and Display Ads

9.2010 | Demo | North America

There is more to this space than a click. Different campaigns objectives need different measurement. At Google, each day, we're making it easier to create, buy, and measure display ads.
Movement Marketing Play Video

Movement Marketing

9.2010 | Interview | North America

Scott Goodson, founder of Strawberry Frog, explains how brands can align with mass movements. Identify a rising issue in the culture and build a well-defined communications strategy around it. The movement becomes the medium.
Customers Need Answers Play Video

Customers Need Answers

9.2010 | Interview | North America

Joshua Palau, VP Search Engine Marketing at Razorfish, explains that health marketing should provide useful information. For example, if a person performs a search as the result of a diagnosis, the first thing they receive should not be a sales pitch. The first thing they should receive is an answer to their question.
Analysis Paralysis Play Video

Analysis Paralysis

9.2010 | Interview | North America

Chuck Sullivan, SVP Global Online Services Worldwide for Hilton, recommends practicing selective analytics to avoid falling prey to analysis paralysis. Remain flexible: people who grow up in industries with strong verticals know what works until there is a disruptive factor. At that point, learn best practices from other industries.
Subway Spokepersons Play Video

Subway Spokepersons

9.2010 | Case Study | North America

Tony Pace, CMO of Subway, describes potentially exciting marketing opportunities. Subway works with famous fans of Subway who have a following in the social media space. Using them in ads and social media will be a major effort in 2011.
ROI & Sponsorship Play Video

ROI & Sponsorship

9.2010 | Interview | North America

Dan Griffis of NASCAR, points out that marketers have moved away from sponsorship because ROI has been harder to prove. Griffis has had to work harder to develop ROI models that make sense.
Social & Branding Play Video

Social & Branding

9.2010 | Interview | North America

David Kirkpatrick,author of The Facebook Effect, notes that there is no motivation for consumers to engage with brands via social media unless the brands acquire acquire personality or functionality to attract them. Brands can be blocked, unfriended, and ignored. Social does not guarantee an audience but if there is engagement, build on it.
Sponsorship Play Video

Sponsorship

9.2010 | Case Study | North America

Dan Griffis is excited about sponsorship with sports and with his own brand, NASCAR. The cost of sponsorship has come down. Savvy, connected people can make sponsorship deals for maximum impact.
Viral Advertising Play Video

Viral Advertising

9.2010 | Interview | North America

Bill Werde, Editorial Director of Billboard, says that the most interesting recent advertising campaigns have been those which have gone viral, because it is inspiring to connect ideas to the people who want them.
Partnerships Online Play Video

Partnerships Online

9.2010 | Interview | North America

John Aman, AVP, Strategic Sponsorships of Nationwide Insurance, discusses innovative advertising. An online owner and a series sponsor can partner together to drive traffic for each other, sharing access points and delivery. This has driven excellent results for Nationwide and Turner / NASCAR.com.
Partner with Regulators Play Video

Partner with Regulators

9.2010 | Interview | North America

Joseph Cowan, Partner and Senior Search Strategist at MEC Global, explains the problem with risk-taking in health marketing. Marketing needs to engage the FDA more closely in beta testing of new marketing platforms. The FDA and the industry need to engage as partners, not antagonists.